Search clinical trials for: SM-020

Total 2916 results

Pharmaceutical Project Solutions, Inc.
Cognitive Research Corporation

Completed

Pharmacokinetic Study of Intranasal RX0041-002 in Hepatic-Impaired Individuals and Subjects With Normal Hepatic Function

Analgesic Allergy

United States
Meir Hospital, Kfar Saba, Israel

Unknown

Assessment of Pain in Surgical Patient by PMD 200

Pain, Postoperative
Celgene

Completed

A Study to Assess the Relative Bioavailability of a New CC-220 Capsule Formulation, Compared to a Reference CC-220 Capsule Formulation, in Healthy Adult Subjects

Healthy Volunteers

United States
Seoul National University Hospital
HK inno.N Corporation; Kureha Corporation

Completed

Kremezin Study Against Renal Disease Progression in Korea (K-STAR)

Chronic Kidney Disease

Korea, Republic of
Chang Gung Memorial Hospital

Completed

Effect of An Oral Absorbent AST-120 in Late-stage Chronic Kidney Disease (CKD) Patients.

Chronic Kidney Disease | AST-120

Taiwan
LivaNova

Completed

Evaluation of the Performances of the Sleep Disordered Breathing Monitoring Function in Pacemaker (DREAM)

Bradycardia

France, Spain
M.D. Anderson Cancer Center
Cellectar Biosciences, Inc.

Withdrawn

NOV-002 in Myelodysplastic Syndrome (MDS)

Leukemia | Myelodysplastic Syndrome
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating IMA-026 in Healthy Japanese Males

Healthy

Japan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating IMA-026 in Healthy Subjects

Healthy

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of MYO-029

Healthy
JADO Technologies GmbH

Completed

Efficacy and Safety of TF002 in Cutaneous Mastocytosis

Cutaneous Mastocytosis

Germany
Atabay Kimya Sanayi Ticaret A.S.
Novagenix Bioanalytical Drug R&D Center; Farmagen Ar-Ge Biyot. Ltd. Sti

Completed

Bioequivalence Study of Favipiravir 200 mg Film Tablet (ATABAY, Turkey) Under Fasting Conditions (Favipiravir)

Bioequivalence

Turkey
Novelfarma Ilaç San. ve Tic. Ltd. Sti.
Novagenix Bioanalytical Drug R&D Center; Farmagen Ar-Ge Biyot. Ltd. Sti

Completed

Bioequivalence Study of Favipiravir 200 mg Film Tablet (Novelfarma, Turkey) Under Fasting Conditions (Favipiravir)

Bioequivalence

Turkey
Bristol-Myers Squibb
Cardioxyl Pharmaceuticals, Inc

Completed

A Dose-Defining Study of CXL-1020 in Patients With Systolic Heart Failure

Heart Failure

United States
Humedix Co., Ltd.

Recruiting

Efficacy and Safety of HMM1-022 in Temporary Correction of Crow's Feet

Crows Feet

Korea, Republic of
Orion Biotechnology Polska Sp. z o.o.

Not yet recruiting

Study of OB-002 in Patients With Refractory Metastatic Cancer

Metastatic Colorectal Cancer | Metastatic Cancer | Metastatic Breast Cancer | Metastatic Urothelial Carcinoma | Metastatic Gastric Cancer | Metastatic Pancreatic Cancer
Keros Therapeutics, Inc.

Recruiting

A Study of KER-050 to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes

Myelodysplastic Syndromes | Cytopenia

Australia, Spain, United States, Israel, France, Germany, New Zealand, Czechia
Beijing InnoCare Pharma Tech Co., Ltd.

Completed

A Study of ICP-022 in Patients With R/R DLBCL (DLBCL)

Diffuse Large B Cell Lymphoma

China
Beijing InnoCare Pharma Tech Co., Ltd.

Completed

A Study of ICP-022 in the Treatment of Recurrent or Refractory Waldenstrom Macroglobulinemia

Waldenstrom's Macroglobulinemia Recurrent | Waldenstrom's Macroglobulinemia Refractory

China
Sonnet BioTherapeutics

Terminated

SON-080 in Patients With Persistent Chemotherapy-induced Peripheral Neuropathy (CIPN)

Chemotherapy-induced Peripheral Neuropathy (CIPN)

Australia
Pyramid Biosciences

Terminated

Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid Tumors

Solid Tumor, Adult | Desmoplastic Small Round Cell Tumor | Brain Tumor, Primary

France, United States, Spain, Hong Kong, United Kingdom, Australia, Singapore, Germany, Korea, Republic of, Italy, Denmark
Daiichi Sankyo

Completed

A Dose Finding Study of VN-0200

Respiratory Syncytial Virus Infections

Japan
Daxor Corporation
Oregon Health and Science University; Stern Cardiovascular Foundation, Inc.

Completed

BVA-200 vs BVA-100 Validation Study

Heart Failure | Kidney Diseases | Diabetes | Thyroid Diseases | Anemia | Trauma | High Blood Pressure | High Cholesterol | Other Disease | Clotting Disorder

United States
Kinaset Therapeutics Inc

Active, not recruiting

Single and Multiple Ascending Dose Study of KN-002 (KN-002)

Asthma COPD

United Kingdom
Tianjin Chasesun Pharmaceutical Co., LTD

Enrolling by invitation

A Study of IMMH-010 in Patients With Advanced Malignant Solid Tumors

Malignant Neoplasms

China
Codiak BioSciences

Completed

A First-in-Human Study of CDK-002 (exoSTING) in Subjects With Advanced/Metastatic, Recurrent, Injectable Solid Tumors

Advanced Solid Tumor

United States, United Kingdom
Coordination Pharmaceuticals, Inc.

Completed

Study of CPI-200 in Patients With Advanced Tumors

Advanced Solid Tumor

United States
Palvella Therapeutics, Inc.

Active, not recruiting

VALO-2: Study Evaluating the Safety and Efficacy of PTX022 in the Treatment of Adults With Pachyonychia Congenita (VALO-2)

Pachyonychia Congenita

United States
Synthetic Biologics Inc.

Completed

A Single-Dose, Open-Label, Study to Evaluate the Sustainability of the Effects of SYN-010 in Patients With IBS-C

Irritable Bowel Syndrome With Constipation (IBS-C)

United States
Mallinckrodt

Terminated

Trial to Study the Safety of Intravenous MNK-010 in Advanced Solid Tumors

Advanced Solid Tumors

United States
Akinion Pharmaceuticals AB

Terminated

Safety Study of AKN-028 in Patients With Acute Myelogenous Leukemia

Acute Myeloid Leukemia

Sweden, Poland, Czech Republic, United Kingdom
Corindus Inc.

Completed

CorPath™ 200: Robotically-Assisted Percutaneous Coronary Intervention (PCI)

Coronary Artery Disease

Colombia
Ocera Therapeutics

Completed

Safety and Efficacy of AST-120 in Mild to Moderate Crohn's Patients With Fistulas

Intestinal Fistula | Inflammatory Bowel Disease

United States, Israel, Canada, United Kingdom, Germany, Belgium, Hungary, France, Austria, Czech Republic, Netherlands, Poland
Astellas Pharma Inc

Completed

Study of Oral OSI-027 in Patients With Advanced Solid Tumors or Lymphoma

Any Solid Tumor or Lymphoma

United States, Belgium, United Kingdom
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

Study Evaluating EAA-090 in Adult Outpatients With Neuropathic Pain Associated With Diabetic Neuropathy

Diabetes Mellitus | Diabetic Neuropathy, Painful
Flanders Medical Research Program

Completed

DURABILITY-200: EverFlex 200mm Long Nitinol Stents in TASC C&D Femoropopliteal Lesions

Intermittent Claudication | Peripheral Vascular Disease | Critical Limb Ischemia

Belgium
Bristol-Myers Squibb

Withdrawn

MDX-060 in Patients With Relapsed or Refractory Classic Systemic or Primary Cutaneous Anaplastic Large Cell Lymphoma

Lymphoma, Large-Cell

United States, France
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Single Ascending Doses Of ILS-920

Acute Ischemic Stroke
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study of the Safety, Tolerability, and PK of PRA-027 Administered to Women of Nonchildbearing Potential

Fibroid

United States
RxKinetix

Completed

Safety and Efficacy of RK0202 in Oral Mucositis

Head and Neck Cancer | Mouth Diseases | Oral Mucositis | Mouth Ulcers

United States, Canada
University of California, San Diego

Recruiting

The Effects and Mechanisms of a High CBD Cannabis Extract (BRC-002) for the Treatment of Pain and Health in Complex Regional Pain Syndrome

Complex Regional Pain Syndrome

United States
Bukwang Pharmaceutical

Terminated

Study in Parkinson's Disease Patients With Dyskinesia With Combinations of JM-010 and Its Individual Components (SHINE)

Parkinson Disease | Dyskinesias

United States
The Oxford Dental College, Hospital and Research...

Completed

Evaluation of Efficacy of Aloevera in the Treatment of Oral Submucous Fibrosis- A Clinical Study

Oral SubMucous Fibrosis
International Partnership for Microbicides, Inc.
National Institutes of Health (NIH)

Completed

PK and Safety Study of Vaginal Rings Containing Dapivirine and Levonorgestrel (DAP/LNG)

HIV Prevention

United States
Foresee Pharmaceuticals Co., Ltd.

Terminated

A Phase 2/3 Study to Evaluate FP-025 in Patients With Severe to Critical COVID 19

Severe to Critical COVID 19 With Associated ARDS

United States
Memorial Sloan Kettering Cancer Center
Hookipa Biotech GmbH; Naveris

Recruiting

A Study of HB-202/HB-201 in People With Human Papilloma Virus 16-Positive Head and Neck Squamous Cell Cancer (HPV 16+ HNSCC)

HPV16+ Squamous Cell Carcinoma

United States
ImmunoRx Pharma Inc.

Recruiting

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics Following Intravenous Administration of IRX-010 in Healthy Participants

Healthy Participants

Netherlands
Glyscend, Inc.

Recruiting

A 16-Week Study to Evaluate the Efficacy, Safety, and Tolerability of GLY-200 in Participants With Obesity

Obesity

United States
University of Witwatersrand, South Africa
Bill and Melinda Gates Foundation

Recruiting

A Randomised, Multi-centre, Double-blind, Phase 3 Study to Observe the Effectiveness, Safety and Tolerability of Molnupiravir Compared to Placebo Administered Orally to High-risk Adult Outpatients With Mild COVID-19 Receiving Local Standard of Care in South Africa (CoTeT)

COVID-19

South Africa
Shandong University

Not yet recruiting

A Clinical Trial of the Orelabrutinib in the Management of Refractory ITP

Immune Thrombocytopenia | Bruton's Tyrosine Kinase

Search clinical trials for: SM-020

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Poland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations